| abstract |
The invention relates to the medical use of an anti-c-Met antibody-cytotoxic drug conjugate. Specifically, the present invention relates to an anti-c-Met antibody, an antigen-binding fragment of c-Met, a chimeric antibody, a humanized antibody comprising the CDR region of the anti-c-Met antibody, and an antibody-cytotoxic drug conjugate thereof. Or a pharmaceutically acceptable salt or solvent compound thereof, and a pharmaceutical composition comprising a humanized anti-c-Met antibody and an antigen-binding fragment and an antibody-cytotoxic drug conjugate thereof or a pharmaceutically acceptable salt or solvent compound thereof as an anti-liver cancer Use of medicine. |